EP Patent

EP1004294A1 — Pharmaceutical composition comprising a nitric oxide (NO) donating organic compound

Assigned to Promefarm SRL · Expires 2000-05-31 · 26y expired

What this patent protects

A substantially anhydrous pharmaceutical composition comprising a nitric oxide (NO) donating compound, a mucoadhesive compound and an emulsifier capable of forming a microemulsion on addition of water; microemulsion thus obtained.

USPTO Abstract

A substantially anhydrous pharmaceutical composition comprising a nitric oxide (NO) donating compound, a mucoadhesive compound and an emulsifier capable of forming a microemulsion on addition of water; microemulsion thus obtained.

Drugs covered by this patent

nitroglycerin (NITROGLYCERIN)

Patent Metadata

Patent number: EP1004294A1
Jurisdiction: EP
Classification: —
Expires: 2000-05-31
Drug substance claim: No
Drug product claim: No
Assignee: Promefarm SRL
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.